JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Comments
Loading...

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Thursday.

Shares of JOYY Inc. YY fell sharply in today's pre-market trading following weak quarterly sales.

JOYY reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.18 per share. The company reported quarterly sales of $549.45 million which missed the analyst consensus estimate of $549.46 million by 0 percent. This is a 3.58 percent decrease over sales of $569.84 million the same period last year.

JOYY shares dipped 10.9% to $41.75 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Akebia Therapeutics, Inc. AKBA shares fell 26.2% to $2.09 in pre-market trading after the company priced its $50 million public offering of 25 million common shares at $2 per share.
  • Maze Therapeutics, Inc MAZE fell 11.8% to $10.70 in today's pre-market trading.
  • GH Research PLC GHRS declined 7.2% to $11.01 in pre-market trading.
  • Enerflex Ltd. EFXT fell 7.1% to $7.00 in pre-market trading after the company reported that Marc Rossiter has stepped down as President, CEO, and Director.
  • ZTO Express (Cayman) Inc. ZTO declined 5.8% to $20.49 in pre-market trading.
  • Microchip Technology Incorporated MCHP fell 5.5% to $51.54 in pre-market trading after the company announced an offering of $1.35 of billion depository shares.
  • UP Fintech Holding Limited TIGR fell 4.7% to $9.21 in pre-market trading.
  • Regencell Bioscience Holdings Limited RGC fell 2.5% to $30.00 in pre-market trading.

Now Read This:

Photo: zignal_88 on Shutterstock.com

Got Questions? Ask
Which biotech stocks could rebound after AKBA?
How will JOYY's missed sales impact its future growth?
Are there investment opportunities in underperforming tech stocks?
Which small-cap stocks might benefit from current market trends?
How could Microchip Technology's offering affect investors?
What are the potential risks for companies with leadership changes?
Could trade opportunities arise from the decline in ZTO shares?
Which healthcare stocks stand to gain from industry shifts?
Is it time to consider long positions in falling markets?
Which emerging markets could benefit from current market conditions?
Market News and Data brought to you by Benzinga APIs

Posted In: